BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4267678)

  • 21. [Preliminary study on the antianginous and antiarrhythmic efficacy of a new benzofuran derivative: amiodarone].
    Gisonni P; Perrone N; Varriale A; Pessetti G
    Minerva Cardioangiol; 1974 Feb; 22(2):134-7. PubMed ID: 4594905
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of dioxylline phosphate in vascular diseases. Clinical results].
    Rodari T; Tirella G
    Clin Ter; 1972 Jul; 62(1):53-7. PubMed ID: 5071748
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study].
    Coscia M
    Minerva Cardioangiol; 1972 Sep; 20(9):497-504. PubMed ID: 4561065
    [No Abstract]   [Full Text] [Related]  

  • 24. [Results of clinical testing of a circulatory geriatric agent with vitamins].
    Bense K; Schwarz A
    Landarzt; 1967 Dec; 43(34):1690-1. PubMed ID: 5610818
    [No Abstract]   [Full Text] [Related]  

  • 25. [Results of the use of vasoactive preparation pikamilon in pigmented retinal abiotrophy].
    Davydova GA; Mukha AI
    Vestn Oftalmol; 1995; 111(3):20-2. PubMed ID: 7483195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical experimentation on the tolerance and efficacy of Lamuran administered by phleboclysis in 39 patients with peripheral vascular diseases].
    Dotti GC
    Minerva Med; 1973 May; 64(34):1821-30. PubMed ID: 4719379
    [No Abstract]   [Full Text] [Related]  

  • 27. Preliminary results in the treatment of peripheral arteriopathies with a new pharmacologic substance: I-(2"pyrimidyl)4 piperonyl piperazine (ET 495).
    Royer RJ
    Bibl Cardiol; 1969; 26():174-9. PubMed ID: 5402343
    [No Abstract]   [Full Text] [Related]  

  • 28. [Action of 1035 MD on senile macular degeneration; its normotensive effect on the central retinal artery].
    Jézégabel C; Rossazza C
    Bull Soc Ophtalmol Fr; 1970; 70(7):790-7. PubMed ID: 5526305
    [No Abstract]   [Full Text] [Related]  

  • 29. [Buflomedil chlorhydrate in the treatment of retinopathies].
    Spallone A; Porta E; Bertazzi E; Ridling P; Ortolina S; Fatigati G; Carlevaro G; Visentin E; Capilli G
    Clin Ter; 1987 Apr; 121(2):125-8. PubMed ID: 2956000
    [No Abstract]   [Full Text] [Related]  

  • 30. [Trial of praxilene, new vasodilator, in a vascular surgery department].
    Descotes J; Vieville C
    Angeiologie; 1968; 20(4):51-4. PubMed ID: 5710183
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of treatment on oxygen absorption kinetics in patients with retinal dystrophy.
    Trutneva KV; Zaretskaya RB; Milyavskaya TI; Epstein IM; Bruyakina NA
    Metab Pediatr Ophthalmol; 1980; 4(4):197-200. PubMed ID: 7206908
    [No Abstract]   [Full Text] [Related]  

  • 32. [On the treatment of arterial circulatory disorders of the retina and optic nerve].
    Hager H
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1968; 68():382-9. PubMed ID: 5756803
    [No Abstract]   [Full Text] [Related]  

  • 33. [Reaction of the conjunctival and retinal vessels to the administration of vasodilators to patients with vascular disorders of the fundus oculi].
    Davydova NG; Bunin AIa; Nikol'skaia VV; Lysenko VS; Iakovleva AA
    Vestn Oftalmol; 1985; 101(3):38-40. PubMed ID: 4035869
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of citrate nicamétate at high doses in cardiovascular surgery].
    Stankowiak C; Vandecasteele J; Soots G
    Lille Med; 1973 Nov; 18(9):1039-42. PubMed ID: 4211730
    [No Abstract]   [Full Text] [Related]  

  • 35. [Indications and results of the use of 4091 CB in ophthalmology].
    Le Hunsec J
    Bord Med; 1972 Mar; 5(6):731-6. PubMed ID: 5054775
    [No Abstract]   [Full Text] [Related]  

  • 36. [Action of lipotropic agents in the treatment of involutional diseases of the eye].
    Boschetti G; Bellandi F
    Minerva Oftalmol; 1969; 11(2):48-55. PubMed ID: 4097163
    [No Abstract]   [Full Text] [Related]  

  • 37. [Ophthalmological use of bencyclane and ophthalmodynamometric recording of its effect on cerebral vessels].
    Födö V
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1450+. PubMed ID: 5536669
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of peripheral vascular disorders with dilatol].
    Knapik Z; Twardzicki J; Wlodarczykowa J
    Pol Tyg Lek; 1965 Jun; 20(23):846-8. PubMed ID: 5841123
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of xanthinol nicotinate on the small blood vessels.
    Davis E; Rozov H
    Bibl Anat; 1973; 11():334-9. PubMed ID: 4789059
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical experience with bencyclane in the treatment of vascular obliterations in the limbs].
    Krakovskij NI; Taranovic VA
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1435+. PubMed ID: 5536665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.